2025. Real-world Experience with Advanced Long-term Prophylaxis Agents to Treat Hereditary Angioedema in Canada. Actualité en allergologie et en immunologie au Canada. 5, s01 (mars 2025), 2–9. DOI:https://doi.org/10.58931/cait.2025.5s0176.